Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vibrotactile neuro-feedback plus EGb 761 for presby vertigo
2014-000303-28Phase 4Completed
- Sponsor
- Schwabe Group
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ginkgo biloba extract in presbyvestibulopathy (PVP) and vertigo (2 arms), sponsored by Schwabe Group. Primary endpoint: Change of tendency of falling. Started Aug 2014; status: completed.
02
Drugs
ginkgo biloba extract
03
Conditions
presbyvestibulopathy (PVP)vertigo
Beyond the preview
Go deeper on 2014-000303-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000303-28.